Header Logo

Connection

Joan Walker to Genetic Markers

Back to Details
This is a "connection" page, showing publications Joan Walker has written about Genetic Markers.
Joan Walker
Connection Strength
0.026
Genetic Markers
  1. Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer. Gynecol Oncol. 2012 Nov; 127(2):345-50.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.